Skip to main content

Advertisement

Log in

A Comparison of Nicardipine and Labetalol for Acute Hypertension Management Following Stroke

  • ORIGINAL ARTICLE
  • Published:
Neurocritical Care Aims and scope Submit manuscript

Abstract

Objective

Evaluate the ease of use and tolerability of labetalol (L) and nicardipine (N) for hypertension management in patients with acute stroke.

Methods

This is a retrospective, non-randomized study. Consecutive adults within 24 h of hospital admission who received intravenous bolus labetalol or nicardipine infusion as first-line antihypertensive therapy were identified. Hemodynamic data were collected through 24 h of therapy.

Results

Ninety patients received either labetalol (N = 64) or nicardipine (N = 26) initially for blood pressure (BP) management. Stroke types were 54% intracerebral hemorrhage (ICH), 22% subarachnoid hemorrhage, and 23% ischemic stroke and were similar between the two drug groups. Baseline patient characteristics and disease severity (APACHE II and GCS) were similar between groups. The average total daily labetalol dose was 40 (10–340) mg and nicardipine infusion was 5 (1–14) mg/h. Initial BP was similar in the two groups. The nicardipine group had less BP variability (N 8.19 vs. L 10.78 mmHg; p = 0.003), fewer dosage adjustments [L 4 (1–17), N 2 (0–5); p < 0.001] and fewer additional antihypertensive agents (L 33%, N 8%; p = 0.013) administered during the 24-h observation period. In patients with ICH, 33% of nicardipine-treated patients achieved target BP within the first 60 min versus 6% of the L group (p = 0.02). Overall, incidence of hypotension (SBP < 90 mmHg) (L 3%; N 0%) and bradycardia (HR < 60 beats per min) (L 20.6%; N 12%) were comparable between the groups.

Conclusions

Nicardipine offers an alternative to labetalol with similar tolerability and appears to provide a smoother blood pressure control compared to labetalol.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2

Similar content being viewed by others

References

  1. Ohkuma H, Tsurutani H, Suzuki S. Incidence and significance of early aneurysmal rebleeding before neurosurgical or neurological management. Stroke 2001;32(5):1176–80.

    PubMed  CAS  Google Scholar 

  2. Ohwaki K, Yano E, Nagashima H, Hirata M, Nakagomi T, Tamura A. Blood pressure management in acute intracerebral hemorrhage: relationship between elevated blood pressure and hematoma enlargement. Stroke 2004;35(6):1364–7.

    Article  PubMed  Google Scholar 

  3. Zazulia AR, Diringer MN, Derdeyn CP, Powers WJ. Progression of mass effect after intracerebral hemorrhage. Stroke 1999;30(6):1167–73.

    PubMed  CAS  Google Scholar 

  4. Kazui S, Minematsu K, Yamamoto H, Sawada T, Yamaguchi T. Predisposing factors to enlargement of spontaneous intracerebral hematoma. Stroke 1997;28(12):2370–5.

    PubMed  CAS  Google Scholar 

  5. Fujii Y, Takeuchi S, Sasaki O, Minakawa T, Tanaka R. Multivariate analysis of predictors of hematoma enlargement in spontaneous intracerebral hemorrhage. Stroke 1998;29(6):1160–6.

    PubMed  CAS  Google Scholar 

  6. Leira R, Davalos A, Silva Y, et al. Early neurologic deterioration in intracerebral hemorrhage: predictors and associated factors. Neurology 2004;63(3):461–7.

    PubMed  CAS  Google Scholar 

  7. Dandapani BK, Suzuki S, Kelley RE, Reyes-Iglesias Y, Duncan RC. Relation between blood pressure and outcome in intracerebral hemorrhage. Stroke 1995;26(1):21–4.

    PubMed  CAS  Google Scholar 

  8. Leonardi-Bee J, Bath PM, Phillips SJ, Sandercock PA. Blood pressure and clinical outcomes in the International Stroke Trial. Stroke 2002;33(5):1315–20.

    Article  PubMed  Google Scholar 

  9. Castillo J, Leira R, Garcia MM, Serena J, Blanco M, Davalos A. Blood pressure decrease during the acute phase of ischemic stroke is associated with brain injury and poor stroke outcome. Stroke 2004;35(2):520–6.

    Article  PubMed  Google Scholar 

  10. Okumura K, Ohya Y, Maehara A, Wakugami K, Iseki K, Takishita S. Effects of blood pressure levels on case fatality after acute stroke. J Hypertens 2005;23(6):1217–23.

    Article  PubMed  CAS  Google Scholar 

  11. Willmot M, Leonardi-Bee J, Bath PM. High blood pressure in acute stroke and subsequent outcome: a systematic review. Hypertension 2004;43(1):18–24.

    Article  PubMed  CAS  Google Scholar 

  12. Halpern NA, Goldberg M, Neely C, et al. Postoperative hypertension: a multicenter, prospective, randomized comparison between intravenous nicardipine and sodium nitroprusside. Crit Care Med 1992;20(12):1637–43.

    Article  PubMed  CAS  Google Scholar 

  13. Dorman T, Thompson DA, Breslow MJ, Lipsett PA, Rosenfeld BA. Nicardipine versus nitroprusside for breakthrough hypertension following carotid endarterectomy. J Clin Anesth 2001;13(1):16–9.

    Article  PubMed  CAS  Google Scholar 

  14. O’Malley K, Segal JL, Israili ZH, Boles M, McNay JL, Dayton PG. Duration of hydralazine action in hypertension. Clin Pharmacol Ther 1975;18(5 Pt 1):581–6.

    PubMed  CAS  Google Scholar 

  15. James DJ, Bedford RF. Hydralazine for controlled hypotension during neurosurgical operations. Anesth Analg 1982;61(12):1016–9.

    Article  PubMed  CAS  Google Scholar 

  16. Broderick JP, Adams HP Jr, Barsan W, et al. Guidelines for the management of spontaneous intracerebral hemorrhage: A statement for healthcare professionals from a special writing group of the Stroke Council, American Heart Association. Stroke 1999;30(4):905–15.

    PubMed  CAS  Google Scholar 

  17. Adams HP Jr., Adams RJ, Brott T, et al. Guidelines for the early management of patients with ischemic stroke: A scientific statement from the Stroke Council of the American Stroke Association. Stroke 2003;34(4):1056–83.

    Article  PubMed  Google Scholar 

  18. Adams HP Jr., del Zoppo G, Alberts MJ, et al. Guidelines for the early management of adults with ischemic stroke: a guideline from the American Heart Association/American Stroke Association Stroke Council, Clinical Cardiology Council, Cardiovascular Radiology and Intervention Council, and the Atherosclerotic Peripheral Vascular Disease and Quality of Care Outcomes in Research Interdisciplinary Working Groups: the American Academy of Neurology affirms the value of this guideline as an educational tool for neurologists. Stroke 2007;38(5):1655–711.

    Article  PubMed  Google Scholar 

  19. Griffith DN, James IM, Newbury PA, Woollard ML. The effect of beta-adrenergic receptor blocking drugs on cerebral blood flow. Br J Clin Pharmacol 1979;7(5):491–4.

    PubMed  CAS  Google Scholar 

  20. Olsen KS, Svendsen LB, Larsen FS, Paulson OB. Effect of labetalol on cerebral blood flow, oxygen metabolism and autoregulation in healthy humans. Br J Anaesth 1995;75(1):51–4.

    PubMed  CAS  Google Scholar 

  21. Powers WJ, Zazulia AR, Videen TO, et al. Autoregulation of cerebral blood flow surrounding acute (6 to 22 hours) intracerebral hemorrhage. Neurology 2001;57(1):18–24.

    Article  PubMed  CAS  Google Scholar 

  22. Haas CE, LeBlanc JM. Acute postoperative hypertension: a review of therapeutic options. Am J Health Syst Pharm 2004;61(16):1661–73; quiz 1674–5.

    PubMed  CAS  Google Scholar 

  23. Varon J, Marik PE. The diagnosis and management of hypertensive crises. Chest 2000;118(1):214–27.

    Article  PubMed  CAS  Google Scholar 

  24. Steiner T, Kaste M, Forsting M, et al. Recommendations for the management of intracranial haemorrhage—part I: spontaneous intracerebral haemorrhage. The European Stroke Initiative Writing Committee and the Writing Committee for the EUSI Executive Committee. Cerebrovasc Dis 2006;22(4):294–316.

    Article  PubMed  Google Scholar 

  25. Broderick JP, Brott TG, Duldner JE, Tomsick T, Huster G. Volume of intracerebral hemorrhage. A powerful and easy-to-use predictor of 30-day mortality. Stroke 1993;24(7):987–93.

    PubMed  CAS  Google Scholar 

  26. Rose JC, Mayer SA. Optimizing blood pressure in neurological emergencies. Neurocrit Care 2004;1(3):287–99.

    Article  PubMed  Google Scholar 

  27. Qureshi AI, Harris-Lane P, Kirmani JF, et al. Treatment of acute hypertension in patients with intracerebral hemorrhage using American Heart Association guidelines. Crit Care Med 2006;34(1):1975–80.

    Article  PubMed  Google Scholar 

  28. Kazui S, Naritomi H, Yamamoto H, Sawada T, Yamaguchi T. Enlargement of spontaneous intracerebral hemorrhage. Incidence and time course Stroke 1996;27(10):1783–7.

    PubMed  CAS  Google Scholar 

  29. Brott T, Broderick J, Kothari R, et al. Early hemorrhage growth in patients with intracerebral hemorrhage. Stroke 1997;28(1):1–5.

    PubMed  CAS  Google Scholar 

Download references

Acknowledgment

Financial disclosure: Drs. Coplin and Rhoney are on the speakers’ bureau for, and receive research support from PDL BioPharma.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Denise H. Rhoney.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Liu-DeRyke, X., Janisse, J., Coplin, W.M. et al. A Comparison of Nicardipine and Labetalol for Acute Hypertension Management Following Stroke. Neurocrit Care 9, 167–176 (2008). https://doi.org/10.1007/s12028-008-9057-z

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12028-008-9057-z

Keywords

Navigation